Tawk Hani M, Vickery Karen, Bisset Linda, Lo Sing Kai, Cossart Yvonne E
Department of Infectious Diseases and Immunology, University of Sydney, Sydney, Australia.
Transfusion. 2005 May;45(5):807-13. doi: 10.1111/j.1537-2995.2005.04317.x.
The objective was to determine the contribution of transfusion in the past to the risk of current infection with hepatitis B or C among patients attending a large hospital for endoscopic procedures.
Blood samples had been tested for hepatitis markers by routine methods. Patients completed a comprehensive risk factor questionnaire and results were analyzed using computer software.
Twenty-seven percent of the 2120 participants in the study received transfusions in the past. There was no increase in prevalence of hepatitis B among those transfused. Compared with nontransfused participants, recipients of blood before the implementation of hepatitis C virus (HCV) screening in 1990 had a 4.6-fold increased risk of HCV infection, whereas those transfused with screened blood had a 3-fold increased risk. The difference between the odds ratios for patients before and after screening was not significant.
Because screening has almost completely eliminated HCV from the blood supply, our finding of a continuing association of HCV infection with transfusion was unexpected. It implies that there are significant other nosocomial risks for hepatitis C transmission associated with the clinical situations where patients received blood. These should be actively investigated.
目的是确定过去输血对一家大型医院接受内镜检查的患者当前感染乙型或丙型肝炎风险的影响。
采用常规方法对血样进行肝炎标志物检测。患者完成一份综合风险因素问卷,并使用计算机软件对结果进行分析。
该研究的2120名参与者中,27%的人过去接受过输血。输血者中乙型肝炎的患病率没有增加。与未输血的参与者相比,1990年丙型肝炎病毒(HCV)筛查实施前接受输血的人感染HCV的风险增加了4.6倍,而接受筛查后血液输血的人感染风险增加了3倍。筛查前后患者的优势比差异不显著。
由于筛查几乎已将HCV从供血中完全消除,我们发现HCV感染与输血之间仍存在关联,这一结果出乎意料。这意味着在患者接受输血的临床情况下,还存在其他重大的丙型肝炎医院感染传播风险。对此应积极开展调查。